Top

Molecular Imaging and Biology

Published in:

01-04-2019 | Research Article

Associations Between [¹⁸F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

Authors: Alexey Surov, Hans Jonas Meyer, Anne-Kathrin Höhn, Karsten Winter, Osama Sabri, Sandra Purz

Published in: Molecular Imaging and Biology | Issue 2/2019

Abstract

Purpose

Head and neck squamous cell carcinoma (HNSCC) is one of common cancers worldwide. Positron emission tomography (PET) with 2-deoxy-2-[¹⁸F]fluoro-d-glucose ([¹⁸F]FDG) is increasingly used for diagnosing and staging, as well as for monitoring of treatment of HNSCC. PET parameters like maximum and mean standard uptake values (SUV_max, SUV_mean) can predict the behavior of HNSCC. The purpose of this study was to analyze possible associations between these PET parameters and clinically relevant histopathological features in patients with HNSCC.

Procedures

Overall, 22 patients, mean age, 55.2 ± 11.0 years, with different HNSCC were acquired. Low grade (G1/2) tumors were diagnosed in 10 cases (45 %) and high grade (G3) tumor in 12 (55 %) patients. In all cases, whole body PET was performed. For this study, the following specimen stainings were performed: MIB-1 staining (KI 67 expression), epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), tumor suppressor protein p53, hypoxia-inducible factor (HIF)-1α, and human papilloma virus (p16 expression). All stained specimens were digitalized and analyzed by using the ImageJ software 1.48v. Spearman’s correlation coefficient (ρ) was used to analyze associations between investigated parameters. P values <0.05 were taken to indicate statistical significance.

Results

P16-negative tumors showed statistically significant higher SUV_max (ρ = 0.006) and SUV_mean values (ρ = 0.002) in comparison to p16-positive carcinomas. No significant differences were identified in the analyzed parameters between poorly and moderately/well-differentiated tumors. In overall sample, there were no statistically significant correlations between the [¹⁸F]FDG-PET and histopathological parameters. Also, in G1/2 tumors, no significant correlations were identified. In G3 carcinomas, cell count correlated statistical significant with SUV_max (p = 0.580, P = 0.048) and SUV_mean (ρ = 0.587, P = 0.045).

Conclusion

Associations between [¹⁸F]FDG-PET parameters and different histopathological features in HNSCC depend significantly on tumor grading. In G1/2 carcinomas, there were no significant correlations between [¹⁸F]FDG-PET parameters and histopathology. In G3 lesions, SUV_max and SUV_mean reflect tumor cellularity.

Braakhuis BJ, Leemans CR, Visser O (2014) Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol 50:670–675CrossRefPubMed

Adams S, Baum RP, Stuckensen T, Bitter K, Hör G (1998) Prospective comparison of ¹⁸F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 25:1255–1260CrossRefPubMed

Ng SH, Yen TC, Liao CT, Chang JT, Chan SC, Ko SF, Wang HM, Wong HF (2005) 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46:1136–1143PubMed

Surov A, Stumpp P, Meyer HJ, Gawlitza M, Höhn AK, Boehm A, Sabri O, Kahn T, Purz S (2016) Simultaneous 18F-FDG-PET/MRI: associations between diffusion, glucose metabolism and histopathological parameters in patients with head and neck squamous cell carcinoma. Oral Oncol 58:14–20CrossRefPubMed

Varoquaux A, Rager O, Poncet A, Delattre BMA, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H, Becker M (2014) Detection and quantification of focal uptake in head and neck tumours: ¹⁸F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging 41:462–475CrossRefPubMed

Goel R, Moore W, Sumer B, Khan S, Sher D, Subramaniam RM (2017) Clinical practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer. AJR Am J Roentgenol 209:289–303CrossRefPubMed

Chan SC, Cheng NM, Hsieh CH, Ng SH, Lin CY, Yen TC, Hsu CL, Wan HM, Liao CT, Chang KP, Wang JJ (2017) Multiparametric imaging using ¹⁸F-FDG PET/CT heterogeneity parameters and functional MRI techniques: prognostic significance in patients with primary advanced oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. Oncotarget 8:62606–62621PubMedPubMedCentral

Ryu IS, Roh JL, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2016) Impact of ¹⁸F -FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. Eur J Cancer 63:88–96CrossRefPubMed

Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT (2010) Is there a correlation between ¹⁸F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck? Eur Arch Otorhinolaryngol 267:1635–1640CrossRefPubMed

10.

Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, el-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM (2015) ¹⁸F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers? Eur J Radiol 84:1171–1176CrossRefPubMedPubMedCentral

11.

Li SJ, Guo W, Ren GX, Huang G, Chen T, Song SL (2008) Expression of Glut-1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2-[¹⁸F]fluoro-2-deoxy-D-glucose accumulation in positron emission tomography. Br J Oral Maxillofac Surg 46:180–186CrossRefPubMed

12.

Abgral R, Keromnes N, Robin P, le Roux PY, Bourhis D, Palard X, Rousset J, Valette G, Marianowski R, Salaün PY (2014) Prognostic value of volumetric parameters measured by ¹⁸F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging 41:659–667CrossRefPubMed

13.

Kim SY, Roh JL, Kim JS, Ryu CH, Lee JH, Cho KJ, Choi SH, Nam SY (2008) Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34:208–215CrossRefPubMed

14.

Kitagawa Y, Sano K, Nishizawa S, Nakamura M, Ogasawara T, Sadato N, Yonekura Y (2003) FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30:63–71CrossRefPubMed

15.

Wong KH, Panek R, Welsh L, Mcquaid D, Dunlop A, Riddell A, Murray I, du Y, Chua S, Koh DM, Bhide S, Nutting C, Oyen WJG, Harrington K, Newbold KL (2016) The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/CT and diffusion-weighted MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 57:1843–1850CrossRefPubMed

16.

Rasmussen GB, Vogelius IR, Rasmussen JH, Schumaker L, Ioffe O, Cullen K, Fischer BM, Therkildsen MH, Specht L, Bentzen SM (2015) Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma. Acta Oncol 54:1408–1415CrossRefPubMed

17.

Troy JD, Weissfeld JL, Youk AO, Thomas S, Wang L, Grandis JR (2013) Expression of EGFR, VEGF, and NOTCH1 suggest differences in tumor angiogenesis in HPV-positive and HPV-negative head and neck squamous cell carcinoma. Head Neck Pathol 7:344–355CrossRefPubMedPubMedCentral

18.

Grönroos TJ, Lehtiö K, Söderström KO, Kronqvist P, Laine J, Eskola O, Viljanen T, Grénman R, Solin O, Minn H (2014) Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET. BMC Cancer 14:876CrossRefPubMedPubMedCentral

19.

Zhao K, Yang SY, Zhou SH et al (2014) Fluorodeoxyglucose uptake in laryngeal carcinoma is associated with the expression of glucose transporter 1 and hypoxia inducible factor 1α and the phosphoinositide 3 kinase/protein kinase B pathway. Oncol Lett 7:984–990CrossRefPubMedPubMedCentral

20.

Han MW, Lee HJ, Cho KJ, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY (2012) Role of FDG-PET as a biological marker for predicting the hypoxic status of tongue cancer. Head Neck 34:1395–1402CrossRefPubMed

21.

Surov A, Gottschling S, Mawrin C, Prell J, Spielmann RP, Wienke A, Fiedler E (2015) Diffusion weighted imaging in meningioma: prediction of tumor grade and association with histopathological parameters. Transl Oncol 8:517–523CrossRefPubMedPubMedCentral

22.

Surov A, Caysa H, Wienke A, Spielmann RP, Fiedler E (2015) Correlation between different ADC fractions, cell count, Ki-67, total nucleic areas and average nucleic areas in meningothelial meningiomas. Anticancer Res 35:6841–6846PubMed

23.

Doll CM, Moughan J, Klimowicz A, Ho CK, Kornaga EN, Lees-Miller SP, Ajani JA, Crane CH, Kachnic LA, Okawara GS, Berk LB, Roof KS, Becker MJ, Grisell DL, Ellis RJ, Sperduto PW, Marsa GW, Guha C, Magliocco AM (2017) Significance of co-expression of epidermal growth factor receptor and Ki67 on clinical outcome in patients with anal cancer treated with chemoradiotherapy: an analysis of NRG oncology RTOG 9811. Int J Radiat Oncol Biol Phys 97:554–562CrossRefPubMed

24.

Almangush A, Heikkinen I, Mäkitie AA, Coletta RD, Läärä E, Leivo I, Salo T (2017) Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis. Br J Cancer 117:856–866CrossRefPubMedPubMedCentral

25.

Gioacchini FM, Alicandri-Ciufelli M, Magliulo G, Rubini C, Presutti L, Re M (2015) The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 272:1569–1576CrossRefPubMed

26.

Oliveira LR, Ribeiro-Silva A (2011) Prognostic significance of immunohistochemical biomarkers in oral squamous cell carcinoma. Int J Oral Maxillofac Surg 40:298–307CrossRefPubMed

27.

Bossi P, Resteghini C, Paielli N, Licitra L, Pilotti S, Perrone F (2016) Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma. Oncotarget 7:74362–74379CrossRefPubMedPubMedCentral

28.

Ma X, Huang J, Wu X, Li X, Zhang J, Xue L, Li P, Liu L (2014) Epidermal growth factor receptor could play a prognostic role to predict the outcome of nasopharyngeal carcinoma: a meta-analysis. Cancer Biomark 14:267–277CrossRefPubMed

29.

Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomark Prev 19:574–587CrossRef

30.

Zang J, Li C, Zhao LN, Shi M, Zhou YC, Wang JH, Li X (2013) Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: a meta-analysis. Head Neck 35:1507–1514PubMed

31.

Melkane AE, Auperin A, Saulnier P, Lacroix L, Vielh P, Casiraghi O, Msakni I, Drusch F, Temam S (2014) Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas. Head Neck 36:257–265CrossRefPubMed

32.

Gong L, Zhang W, Zhou J, Lu J, Xiong H, Shi X, Chen J (2013) Prognostic value of HIFs expression in head and neck cancer: a systematic review. PLoS ON 8:e75094CrossRef

33.

Yokobori Y, Toyoda M, Sakakura K, Kaira K, Tsushima Y, Chikamatsu K (2015) ¹⁸F-FDG uptake on PET correlates with biological potential in early oral squamous cell carcinoma. Acta Otolaryngol 135:494–499CrossRefPubMed

34.

Deron P, Vangestel C, Goethals I, de Potter A, Peeters M, Vermeersch H, van de Wiele C (2011) FDG uptake in primary squamous cellcarcinoma of the head and neck. The relationship between over expression of glucose transporters and hexokinases, tumour proliferation and apoptosis. Nuklearmedizin 50:15–21PubMed

35.

Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R (2001) [Fluorine-18] Fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. ORL 63:307–313CrossRefPubMed

36.

Norikane T, Yamamoto Y, Maeda Y, Kudomi N, Matsunaga T, Haba R, Iwasaki A, Hoshikawa H, Nishiyama Y (2014) Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with ¹⁸F-FDG PET. Nucl Med Commun 35:30–35CrossRefPubMed

37.

Leifels L, Purz S, Stumpp P, Schob S, Meyer HJ, Kahn T, Sabri O, Surov A (2017) Associations between 18F-FDG-PET, DWI, and DCE parameters in patients with head and neck squamous cell carcinoma depend on tumor grading. Contrast Media Mol Imaging 5369625

38.

Wadhwan V, Sharma P, Saxena C et al (2015) Grading angiogenesis in oral squamous cell carcinoma: a histomorphometric study. Indian J Dent Res 26:26–30CrossRefPubMed

39.

Anneroth G, Hansen LS (1984) A methodologic study of histologic classification and grading of malignancy in oral squamous cell carcinoma. Scand J Dent Res 92:448–468PubMed

40.

Schouten CS, Hakim S, Boellaard R, Bloemena E, Doornaert PA, Witte BI, Braakhuis BJM, Brakenhoff RH, Leemans CR, Hoekstra OS, de Bree R (2016) Interaction of quantitative ¹⁸F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. Head Neck 38:529–535CrossRefPubMed

Title: Associations Between [18F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma
Authors: Alexey Surov
Hans Jonas Meyer
Anne-Kathrin Höhn
Karsten Winter
Osama Sabri
Sandra Purz
Publication date: 01-04-2019
Publisher: Springer International Publishing
Published in: Molecular Imaging and Biology / Issue 2/2019
Print ISSN: 1536-1632
Electronic ISSN: 1860-2002
DOI: https://doi.org/10.1007/s11307-018-1223-x

ACC 2024 Congress

Springer Medicine

Associations Between [¹⁸F]FDG-PET and Complex Histopathological Parameters Including Tumor Cell Count and Expression of KI 67, EGFR, VEGF, HIF-1α, and p53 in Head and Neck Squamous Cell Carcinoma

Abstract

Purpose

Procedures

Results

Conclusion

ACC 2024 Congress

Springer Medicine

Abstract

Purpose

Procedures

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2019

Influence of Multidrug Resistance-Associated Proteins on the Excretion of the ABCC1 Imaging Probe 6-Bromo-7-[11C]Methylpurine in Mice

Evaluation of Glucose Uptake and Uncoupling Protein 1 Activity in Adipose Tissue of Diabetic Mice upon β-Adrenergic Stimulation

Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation

In Vivo Evaluation of Magnetic Targeting in Mice Colon Tumors with Ultra-Magnetic Liposomes Monitored by MRI

SNAPshots of the MCHR1: a Comparison Between the PET-Tracers [18F]FE@SNAP and [11C]SNAP-7941

Imaging Pulmonary Foreign Body Reaction Using [125I]iodo-DPA-713 SPECT/CT in Mice